Posts Tagged: "opiod"

The Federal Circuit reversed the District of Delaware’s decision to invalidate Orexo’s opioid treatment patent as obvious because obviousness was not proved by clear and convincing evidence. Specifically, the Court pointed to the absence of a teaching in the prior art that citric acid could serve as a carrier particle for the drug agonist.  The Court also noted that the lower court improperly discounted evidence of objective indicia of nonobviousness.

We reached out to Travelers and were able to confirm through a spokesperson that two patent applications published this year by the U.S. Patent and Trademark Office cover technologies associated with the Early Severity Predictor project. One is U.S. Patent Application No. 20160034662, titled Systems, Methods, and Apparatus for Identifying and Mitigating Potential Chronic Pain in Patients. This would protect an apparatus with a processor determining information about a claim associated with a person including medical condition, employment information and personal information. This information is analyzed to determine an indication that a person will develop chronic pain and the processor further determines a preventative action which can arrest chronic pain development. The technology also covers a dashboard which can be displayed to insurance users, including providers and policyholders alike, which can quickly alert people to high chronic pain risks and pain drivers.